Peter Attia· MD
what the future holds is and there's a push in in our industry and there's a particular association called the biologic Association was like which is like an association of associations internationally where they've formed something called the Barb which is a biological Association um registry and bio um bio it's a bio registry it's a registry and a bio registry that is they have lots of centers and they want to know everything about what you're injecting they want to know what's the concentration of the blood of the patient and how what percentage of docs who are regularly giving this therapy are uh participating in the registry to the point where we can generate information very compared to the total amount very few but it's enough people that we can get really good data to find out what's the applic what's the dose what's the critical dose of platelets that we need to affect change what is the and other things we could look at the we can do a proteomic analysis of the actual fluid itself and you match that with outcomes data from the registry so you have a bio repository and a registry combined who did well and what did they get and we say and they save samples of that stuff